These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8277090)

  • 41. Bi-stable wave propagation and early afterdepolarization-mediated cardiac arrhythmias.
    Chang MG; Sato D; de Lange E; Lee JH; Karagueuzian HS; Garfinkel A; Weiss JN; Qu Z
    Heart Rhythm; 2012 Jan; 9(1):115-22. PubMed ID: 21855520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
    Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
    Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K; Sredniawa B; Pasyk S
    Przegl Lek; 2002; 59(7):523-6. PubMed ID: 12516242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiologic mechanisms for ventricular arrhythmias in left ventricular dysfunction: electrolytes, catecholamines and drugs.
    Levy MN; Wiseman MN
    J Clin Pharmacol; 1991 Nov; 31(11):1053-60. PubMed ID: 1753009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome.
    Choi BR; Burton F; Salama G
    J Physiol; 2002 Sep; 543(Pt 2):615-31. PubMed ID: 12205194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Microvolt T-Wave Alternans in Patients With Long QT Syndrome and Its Association With Torsade de Pointes.
    Takasugi N; Goto H; Takasugi M; Verrier RL; Kuwahara T; Kubota T; Toyoshi H; Nakashima T; Kawasaki M; Nishigaki K; Minatoguchi S
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003206. PubMed ID: 26839386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Torsades de pointes and proarrhythmia.
    Ben-David J; Zipes DP
    Lancet; 1993 Jun; 341(8860):1578-82. PubMed ID: 8099651
    [No Abstract]   [Full Text] [Related]  

  • 52. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
    Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanism of pause-induced torsade de pointes in long QT syndrome.
    Liu J; Laurita KR
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):981-7. PubMed ID: 16174020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation.
    Grant AO; Tranquillo J
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):204-5. PubMed ID: 17338768
    [No Abstract]   [Full Text] [Related]  

  • 57. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symposium on the management of ventricular dysrhythmias. Concept of reentry versus automaticity.
    Sasyniuk BI
    Am J Cardiol; 1984 Jul; 54(2):1A-6A. PubMed ID: 6380258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of subendocardial Purkinje network in triggering torsade de pointes arrhythmia in experimental long QT syndrome.
    Ben Caref E; Boutjdir M; Himel HD; El-Sherif N
    Europace; 2008 Oct; 10(10):1218-23. PubMed ID: 18757866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.